Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 2Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Classical hematology 1

Conditions

Lymphoma 1600Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Leukemia, Lymphocytic, Chronic, B-Cell 1090Lymphoma, Follicular 979Lymphoma, Large B-Cell, Diffuse 853Leukemia 790Hodgkin Disease 777Lymphoma, Mantle-Cell 675Leukemia, Myeloid, Acute 540Burkitt Lymphoma 507Lymphoma, B-Cell, Marginal Zone 490Multiple Myeloma 483Myelodysplastic Syndromes 371Lymphoma, Large-Cell, Immunoblastic 366Recurrence 363Lymphoma, T-Cell, Cutaneous 313Neoplasms 309Waldenstrom Macroglobulinemia 307Lymphoma, Large-Cell, Anaplastic 254Mycosis Fungoides 252Lymphoma, B-Cell 231Sezary Syndrome 229Blast Crisis 210Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Myeloproliferative Disorders 205Leukemia, Myelogenous, Chronic, BCR-ABL Positive 189Neoplasms, Plasma Cell 188Leukemia, Myeloid, Accelerated Phase 186Leukemia, Myeloid, Chronic-Phase 179

Interventions

alisporivir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hepatic Insufficiency × Lymphoid × Clear all
NCT00341705 2019-12-17

The Second Multicenter Hemophilia Cohort Study

National Institutes of Health Clinical Center (CC)

Completed
2,565 enrolled
Classical hematologyGastrointestinalLymphoid

Acquired Immunodeficiency Syndrome, Hemophilia A, Hepatitis C, Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Neoplasms, Hepatic Insufficiency

NCT01860326 2016-04-28

Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects

Debiopharm International SA

Phase 1 Completed
32 enrolled
Lymphoid

Lymphoma, Follicular, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡